AstraZeneca has applied for the emergency use authorization of its COVID-19 vaccine in the Philippines, said Food and Drug Administration (FDA) chief Eric Domingo.
AstraZeneca is now the 2nd pharmaceutical company to apply for emergency use in the country following Pfizer’s application last December 2020.
RELATED STORY: UK first worldwide to approve Oxford-Astrazeneca COVID-19 vaccine
Meanwhile, FDA aims to decide on Pfizer’s emergency use by next week, January 14.
“Kahapon, nagbigay ng konting katanungan yung ating mga eksperto na pinadala natin sa sa Pfizer. At binigyan ko sila ng 48 hours to reply and give the information requested by our panel. Pagkatapos nun, ibabalik sa akin ng January 10. And a few days after that, makakagawa na tayo ng desisyon sa kanilang aplikasyon,” explained Domingo during a press briefing.
READ ON: Pfizer applies for emergency use approval in PH
Domingo also explained that the government is expediting the process of approval for Pfizer so that it could receive authorization for emergency usage.
“We are not taking long while waiting. And believe me, we are making this as quick as possible. And I’m quite sure, we’ll be out with the authorization within a week. That is quite short if you compare to other countries,” said Domingo in an interview with ABS-CBN News Channel.
